Skip to content

TECNIS IOL DXW225 (REF DXW225U160)Recalls & reported problems

Johnson & Johnson Surgical Vision, Inc. · TEC SYMF TOR II OB SMPCY 16.0D CYL2.25 · Class 3 · Implant

All models of TECNIS IOL (1344)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05050474764071), received between Jan 26, 2026 and Jan 26, 2026 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 1 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Blurred Vision1
  • Posterior Capsule Opacification1
  • Visual Disturbances1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 26, 2026Adverse Event Without Identified Device or Use Problem

    THE DXW225 MODEL INTRAOCULAR LENS (IOL) WAS IMPLANTED IN THE PATIENT¿S OCULAR SINISTER (LEFT EYE). DURING A FOLLOW-UP VISIT, A FILM WAS OBSERVED BEHIND BOTH LENSES, WHICH IS A KNOWN OCCURRENCE IN APPROXIMATELY 1 IN 5 PATIENTS. THE PATIENT WILL REQUIRE A LASER PROCEDURE TO ADDRESS THE ACCUMULATIONS. THE LENSES WERE NOTED TO BE IN GOOD CONDITION. THE PATIENT LATER REPORTED EXPERIENCING COLOR DISTORTION AND BLURRY VISION IN BOTH EYES STARTING IN (B)(6) 2025, THOUGH THESE ISSUES WERE NOT DEBILITATING. AN FES LASER PROCEDURE WAS PERFORMED (B)(6) 2026. THERE WAS NO INCISION ENLARGEMENT, NO SERIOUS PATIENT INJURY, NO SUTURES, AND NO VITRECTOMY. PATIENT PROGNOSIS POST LASER PROCEDURE WAS REPORTED AS FULL SIGHT RESTORED. THE SUSPECT IOL IS NOT AVAILABLE FOR RETURN AS IT REMANS IMPLANTED. NO FURTHER INFORMATION IS AVAILABLE.

    Patient problems: Blurred Vision; Posterior Capsule Opacification; Visual Disturbances

    MAUDE report 24178498 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page